{"id":"https://openalex.org/W7223178317","doi":"https://doi.org/10.1002/ddr.70398","title":"Advancements of Emerging Thiazole\u2010Based CDKs Inhibitors for Cancer Therapy: From Hits to Clinical Candidates","display_name":"Advancements of Emerging Thiazole\u2010Based CDKs Inhibitors for Cancer Therapy: From Hits to Clinical Candidates","publication_year":2026,"publication_date":"2026-10-22","ids":{"openalex":"https://openalex.org/W7223178317","doi":"https://doi.org/10.1002/ddr.70398"},"language":"en","primary_location":{"id":"doi:10.1002/ddr.70398","doi":"https://doi.org/10.1002/ddr.70398","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ddr.70398","pdf_url":null,"source":{"id":"https://openalex.org/S26306840","display_name":"Drug Development Research","issn_l":"0272-4391","issn":["0272-4391","1098-2299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5136710064","display_name":"Menglin Luo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I190242452","display_name":"Guangdong Pharmaceutical University","ror":"https://ror.org/02vg7mz57","country_code":"CN","type":"education","lineage":["https://openalex.org/I190242452"]},{"id":"https://openalex.org/I58200834","display_name":"Southern Medical University","ror":"https://ror.org/01vjw4z39","country_code":"CN","type":"education","lineage":["https://openalex.org/I58200834"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Menglin Luo","raw_affiliation_strings":["Guangdong Provincial Key Laboratory of New Drug Screening School of Pharmaceutical Science, Southern Medical University Guangzhou PR China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guangdong Provincial Key Laboratory of New Drug Screening School of Pharmaceutical Science, Southern Medical University Guangzhou PR China","institution_ids":["https://openalex.org/I190242452","https://openalex.org/I58200834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5136680370","display_name":"Shuwang Jiang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I190242452","display_name":"Guangdong Pharmaceutical University","ror":"https://ror.org/02vg7mz57","country_code":"CN","type":"education","lineage":["https://openalex.org/I190242452"]},{"id":"https://openalex.org/I58200834","display_name":"Southern Medical University","ror":"https://ror.org/01vjw4z39","country_code":"CN","type":"education","lineage":["https://openalex.org/I58200834"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shuwang Jiang","raw_affiliation_strings":["Guangdong Provincial Key Laboratory of New Drug Screening School of Pharmaceutical Science, Southern Medical University Guangzhou PR China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guangdong Provincial Key Laboratory of New Drug Screening School of Pharmaceutical Science, Southern Medical University Guangzhou PR China","institution_ids":["https://openalex.org/I190242452","https://openalex.org/I58200834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101360228","display_name":"Yufeng Ma","orcid":"https://orcid.org/0009-0003-5250-4075","observed_orcids":["https://orcid.org/0009-0003-5250-4075"]},"institutions":[{"id":"https://openalex.org/I190242452","display_name":"Guangdong Pharmaceutical University","ror":"https://ror.org/02vg7mz57","country_code":"CN","type":"education","lineage":["https://openalex.org/I190242452"]},{"id":"https://openalex.org/I58200834","display_name":"Southern Medical University","ror":"https://ror.org/01vjw4z39","country_code":"CN","type":"education","lineage":["https://openalex.org/I58200834"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yufeng Ma","raw_affiliation_strings":["Guangdong Provincial Key Laboratory of New Drug Screening School of Pharmaceutical Science, Southern Medical University Guangzhou PR China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guangdong Provincial Key Laboratory of New Drug Screening School of Pharmaceutical Science, Southern Medical University Guangzhou PR China","institution_ids":["https://openalex.org/I190242452","https://openalex.org/I58200834"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075903429","display_name":"Pei\u2010Liang Zhao","orcid":"https://orcid.org/0000-0002-9400-922X","observed_orcids":["https://orcid.org/0000-0002-9400-922X"]},"institutions":[{"id":"https://openalex.org/I190242452","display_name":"Guangdong Pharmaceutical University","ror":"https://ror.org/02vg7mz57","country_code":"CN","type":"education","lineage":["https://openalex.org/I190242452"]},{"id":"https://openalex.org/I58200834","display_name":"Southern Medical University","ror":"https://ror.org/01vjw4z39","country_code":"CN","type":"education","lineage":["https://openalex.org/I58200834"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Peiliang Zhao","raw_affiliation_strings":["Guangdong Provincial Key Laboratory of New Drug Screening School of Pharmaceutical Science, Southern Medical University Guangzhou PR China"],"raw_orcid":"https://orcid.org/0000-0002-9400-922X","affiliations":[{"raw_affiliation_string":"Guangdong Provincial Key Laboratory of New Drug Screening School of Pharmaceutical Science, Southern Medical University Guangzhou PR China","institution_ids":["https://openalex.org/I190242452","https://openalex.org/I58200834"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3980,"currency":"USD","value_usd":3980},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.74300452,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"87","issue":"7","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Synthesis and biological activity","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Synthesis and biological activity","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclin-dependent-kinases","display_name":"cyclin-dependent kinases","score":0.9179999828338623},{"id":"https://openalex.org/keywords/cyclin-dependent-kinase-inhibitors","display_name":"cyclin-dependent kinase inhibitors","score":0.9800000190734863},{"id":"https://openalex.org/keywords/thiazole-derivatives","display_name":"thiazole derivatives","score":0.9789999723434448},{"id":"https://openalex.org/keywords/anticancer-drug-discovery","display_name":"anticancer drug discovery","score":0.7559999823570251},{"id":"https://openalex.org/keywords/structure-based-drug-design","display_name":"structure-based drug design","score":0.9700000286102295},{"id":"https://openalex.org/keywords/sns-032","display_name":"SNS-032","score":0.9940000176429749},{"id":"https://openalex.org/keywords/kinase-inhibitor-selectivity","display_name":"kinase selectivity","score":0.7850000262260437},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8550000190734863},{"id":"https://openalex.org/keywords/clinical-candidates","display_name":"clinical candidates","score":0.4449999928474426}],"concepts":[{"id":"https://openalex.org/C124320809","wikidata":"https://www.wikidata.org/wiki/Q46292","display_name":"Cyclin-dependent kinase","level":4,"score":0.6783000230789185},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.5625},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5024999976158142},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4797999858856201},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4666000008583069},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.45509999990463257},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4147000014781952},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3991999924182892},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.3903000056743622},{"id":"https://openalex.org/C2778464347","wikidata":"https://www.wikidata.org/wiki/Q413426","display_name":"Thiazole","level":2,"score":0.3343999981880188},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.3305000066757202},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3264000117778778},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.31380000710487366},{"id":"https://openalex.org/C140608501","wikidata":"https://www.wikidata.org/wiki/Q7318358","display_name":"Review article","level":2,"score":0.2971999943256378},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.29249998927116394},{"id":"https://openalex.org/C89429830","wikidata":"https://www.wikidata.org/wiki/Q735710","display_name":"Scaffold","level":2,"score":0.2915000021457672},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.2759999930858612},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2728999853134155},{"id":"https://openalex.org/C2992092908","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug toxicity","level":3,"score":0.2558000087738037},{"id":"https://openalex.org/C3018146709","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Anticancer drug","level":3,"score":0.25029999017715454}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/ddr.70398","doi":"https://doi.org/10.1002/ddr.70398","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ddr.70398","pdf_url":null,"source":{"id":"https://openalex.org/S26306840","display_name":"Drug Development Research","issn_l":"0272-4391","issn":["0272-4391","1098-2299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320336008","display_name":"National College Students Innovation and Entrepreneurship Training Program","ror":null}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":80,"referenced_works":["https://openalex.org/W1995567333","https://openalex.org/W2016365699","https://openalex.org/W2063421477","https://openalex.org/W2078412962","https://openalex.org/W2084916586","https://openalex.org/W2087280298","https://openalex.org/W2091893155","https://openalex.org/W2114712929","https://openalex.org/W2149469110","https://openalex.org/W2153655497","https://openalex.org/W2158108546","https://openalex.org/W2200454155","https://openalex.org/W2515325371","https://openalex.org/W2551349267","https://openalex.org/W2564423501","https://openalex.org/W2567255685","https://openalex.org/W2590744976","https://openalex.org/W2747235866","https://openalex.org/W2807140874","https://openalex.org/W2902263717","https://openalex.org/W2904945363","https://openalex.org/W2906668607","https://openalex.org/W2907413324","https://openalex.org/W2909349197","https://openalex.org/W2918880577","https://openalex.org/W2952780907","https://openalex.org/W2961997810","https://openalex.org/W2996102910","https://openalex.org/W2996617366","https://openalex.org/W3028004189","https://openalex.org/W3034151867","https://openalex.org/W3120890041","https://openalex.org/W3129864650","https://openalex.org/W3138870262","https://openalex.org/W3184299920","https://openalex.org/W3199373900","https://openalex.org/W3206382902","https://openalex.org/W3208692915","https://openalex.org/W4205359995","https://openalex.org/W4280582616","https://openalex.org/W4281262424","https://openalex.org/W4285005776","https://openalex.org/W4302425185","https://openalex.org/W4318824801","https://openalex.org/W4385383360","https://openalex.org/W4391252956","https://openalex.org/W4399510721","https://openalex.org/W4399592581","https://openalex.org/W4402528165","https://openalex.org/W4405098389","https://openalex.org/W4405973981","https://openalex.org/W4406165804","https://openalex.org/W4408261825","https://openalex.org/W4409208354","https://openalex.org/W4409781029","https://openalex.org/W4411301975","https://openalex.org/W4411302141","https://openalex.org/W4411614125","https://openalex.org/W4411858224","https://openalex.org/W4412977774","https://openalex.org/W4413055594","https://openalex.org/W4414109396","https://openalex.org/W4414371858","https://openalex.org/W4414697373","https://openalex.org/W4415687752","https://openalex.org/W4416674624","https://openalex.org/W4416953341","https://openalex.org/W4417155218","https://openalex.org/W4417356435","https://openalex.org/W7115164889","https://openalex.org/W7117465274","https://openalex.org/W7118001277","https://openalex.org/W7118780050","https://openalex.org/W7125505312","https://openalex.org/W7125946620","https://openalex.org/W7130518628","https://openalex.org/W7134171137","https://openalex.org/W7135088316","https://openalex.org/W7150771581","https://openalex.org/W7154985087"],"related_works":[],"abstract_inverted_index":{"ABSTRACT":[0],"Cyclin\u2010dependent":[1],"kinases":[2],"(CDKs)":[3],"represent":[4],"highly":[5,131],"attractive":[6],"anticancer":[7],"targets":[8],"and":[9,21,36,42,53,66,99,114],"several":[10],"inhibitors":[11,32,89],"have":[12,24],"been":[13],"approved":[14],"for":[15,39,64],"cancer":[16],"therapy.":[17],"However,":[18],"drug":[19,106],"resistance":[20],"dose\u2010dependent":[22],"toxicity":[23],"limited":[25],"clinical":[26],"application.":[27],"Therefore,":[28],"discovering":[29],"new":[30],"CDKs":[31,80],"featuring":[33],"novel":[34],"scaffolds":[35],"high":[37],"selectivity":[38],"disease":[40],"treatment":[41],"target":[43],"research":[44],"remains":[45],"to":[46,93],"attract":[47],"significant":[48],"interest":[49],"from":[50,90],"both":[51],"academics":[52],"industry.":[54],"Recently,":[55],"thiazole":[56,120],"has":[57],"emerged":[58],"as":[59],"a":[60],"privileged":[61],"heterocyclic":[62],"scaffold":[63],"design":[65,107],"synthesis":[67],"of":[68,88,119,129],"antitumor":[69],"drugs":[70],"targeting":[71,122],"CDKs.":[72],"Currently,":[73],"although":[74],"there":[75],"are":[76],"no":[77],"FDA\u2010approved":[78],"thiazole\u2010based":[79],"inhibitors,":[81],"this":[82],"review":[83],"systematically":[84],"summarizes":[85],"the":[86,112],"evolution":[87],"early":[91],"hits":[92],"clinical\u2010stage":[94],"candidates":[95],"including":[96],"GFH009,":[97],"SNS\u2010032,":[98],"JSH\u2010150,":[100],"with":[101,124],"particular":[102,125],"emphasis":[103,126],"on":[104,127],"structure\u2010based":[105],"strategies.":[108],"Furthermore,":[109],"we":[110],"highlight":[111],"challenges":[113],"future":[115],"prospects":[116],"in":[117],"development":[118],"derivatives":[121],"CDKs,":[123],"discovery":[128],"next\u2010generation,":[130],"selective":[132],"inhibitors.":[133]},"counts_by_year":[],"updated_date":"2026-10-23T09:35:12.469056","created_date":"2026-10-22T00:00:00"}